Unique Ingredient Identifier 230OU9XXE4 is listed as a ingredient substance
| RN | 31566-31-1 |
| EC | 250-705-4 |
| NCIT | C80900 |
| RXCUI | 1311165 |
UNII 230OU9XXE4 GLYCERYL MONOSTEARATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AURICULAR (OTIC) | SUSPENSION | 0.5 % |
| DENTAL | PASTE | 64 MG |
| OPHTHALMIC | SUSPENSION | 0.5 % |
| ORAL | CAPSULE, DELAYED ACTION | 2.04 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 1.745 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 0.25 MG |
| ORAL | CAPSULE, HARD GELATIN | 13.75 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 27 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 1.9 MG |
| ORAL | PELLET | 1.9 MG |
| ORAL | TABLET | 8.75 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 0.25 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 1.135 mg |
| ORAL | TABLET, DELAYED ACTION | 1.4 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 0.005 MG |
| ORAL | TABLET, EXTENDED RELEASE | 17 MG |
| ORAL | TABLET, FILM COATED | 1.6 mg |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 7.5 MG |
| ORAL | TABLET, SUSTAINED ACTION | 154 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 264.3 MG |
| RECTAL | SUPPOSITORY | 32.3 MG |
| SUBLINGUAL | TABLET | 1.23 MG |
| TOPICAL | CREAM | 7 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 8.5 %W/W |
| TOPICAL | EMULSION, AEROSOL FOAM | NA |
| TOPICAL | EMULSION, CREAM | 20 %W/W |
| TOPICAL | LOTION | 9 %W/W |
| TOPICAL | OINTMENT | 5 %W/W |
| TOPICAL | SUPPOSITORY | NA |
| TOPICAL | SUSPENSION | 1.25 %W/W |
| VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 1 %W/W |
| VAGINAL | EMULSION, CREAM | 17 % |